In addition to PDA, emerging evidence supports that PI3kinase/mTOR pathways are critical in pancreatic neuroendocrine tumors (PanNETs) due to PTEN deletion, tuberous sclerosis complex mutation and activation of Akt and mTOR [39]. The gene discussed is AKT1; the disease is Patent ductus arteriosus.